Alkermes plc (ALKS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$45.00
+1.52%
Mkt Cap $7.32B
Analyst Ratings
Buy
17
Hold
1
Sell
1
Price Target (31 analysts)
$58.83
Range $50.00 – $65.00
Implied Upside
+30.7%
Consensus $58.83 vs current $45.00